Fenugreek (Trigonella Foenum-Graecum)
Fenugreek is a legume whose seeds have been shown in human studies to have mainly favorable effects on blood sugar and blood lipids.
We evaluated 138 human studies on Fenugreek (Trigonella foenum-graecum), including 64 randomised controlled trials and 30 meta-analyses or systematic reviews; the controlled studies include 3,978 participants in total. As of 11 October 2026.
1. What Is Fenugreek (Trigonella Foenum-Graecum)? Occurrence, Origin and Forms
Fenugreek is an annual legume in the Fabaceae family whose dried seeds are used as a spice and in the traditional medicine of the Mediterranean, Western Asia and South Asia. The seeds taste strong and slightly bitter and have long been part of cooking and home remedies there. Common modern forms are ground seeds, infusions and preserved seed extracts.
Fenugreek grows in warm, dry climates and is cultivated in southern Europe, North Africa, Western Asia and South Asia. It is examined almost exclusively through the seed and the preparations made from it.
Dried seeds are ground, steeped in hot water or extracted with water or alcohol, and part of the seed fibre is separated as galactomannan. Studies have examined whole and ground seeds, infusions, seed extracts and the fibre obtained from the seed.
Forms and Preparations Studied
- Whole dried seeds
- Ground seeds (seed flour)
- Seed infusion or tea
- Seed extract, aqueous or alcoholic
- Fibre obtained from the seed (galactomannan)
- Sprouted seeds
Not covered on this page:
- Blue fenugreek (Trigonella caerulea), a different species
- Guar gum and locust bean gum as other sources of galactomannan
- Combination products with several herbs or other ingredients
- Single isolated seed constituents supplied as a pure substance
2. What Does Fenugreek (Trigonella Foenum-Graecum) Do? Results by Area
| Area | Result in controlled studies | Strength of evidence | Studies | Participants |
|---|---|---|---|---|
| Blood Glucose and Sugar Metabolism | mixed | high | 15 meta-analyses · 21 controlled · 24 other | 1,245 |
| Blood Lipids | mixed | high | 9 meta-analyses · 11 controlled · 9 other | 803 |
| Hormones and Testosterone | mixed | high | 3 meta-analyses · 10 controlled · 6 other | 830 |
| Appetite and Satiety | mostly improved | moderate | 0 meta-analyses · 5 controlled · 0 other | 98 |
| Breastfeeding and Milk Production | mixed | low | 0 meta-analyses · 2 controlled · 5 other | 146 |
| Other investigations | mixed | high | 10 meta-analyses · 35 controlled · 18 other | 2,259 |
How to read the table: counted are human studies whose results concern the area. “High” means at least one meta-analysis and two controlled studies showing improvement, or at least three controlled studies of which three quarters show improvement, with at least 300 participants in total. “Moderate” means at least two controlled studies showing improvement, as a majority, or one meta-analysis alongside controlled studies. “Low” means one controlled study showing improvement. Where an area has no controlled study, the strength of evidence is at most “low” (result “reviews only” or “observational data only”). Everything else is “unclear”. A study counts as showing improvement when at least half of its outcomes in this area improved. Reviews of combination products do not count as meta-analyses; results that only describe side effects or shares of users do not count as an effect. The same study is counted only once.
3. What the Studies Show in Detail
Fenugreek (Trigonella Foenum-Graecum), Blood Glucose and Sugar Metabolism: Human Studies
Meta-analyses of controlled studies, predominantly in type 2 diabetes or prediabetes, found lower fasting blood glucose 31214151819 and lower HbA1c 2312141518 than with control. One of these meta-analyses found no significant difference in fasting blood glucose 2. In a randomized three-year study in prediabetes, fewer people developed type 2 diabetes with ground fenugreek than in the control group 85. Post-meal blood glucose was also lower than with control in several meta-analyses 31214152627. Against metformin, fenugreek in PCOS lowered blood glucose and insulin resistance less strongly, but improved blood lipids more strongly 81. Mainly ground seeds, seed extracts and individual standardized extracts such as Furocyst, Fenfuro and Fenuflakes were studied.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 2 Shabil et al. 2023 | meta-analysis · 894 participants | Fenugreek (seeds, form not specified); vs. Control group | Fasting blood glucose: no difference (MD: 3.70, 95% CI of -27.02, 19.62; p = 0.76); Postprandial blood glucose: no difference (MD: -10.61, 95% CI of -68.48, 47.26; p = 0.72); HbA1c: improved (MD: -0.88, 95% CI -1.49, -0.27; p = 0.00) |
| 3 Kim et al. 2023 | meta-analysis · 706 participants | Fenugreek (form not specified); vs. Control group | Fasting blood glucose: improved (significantly reduced); 2-h plasma glucose during OGTT: improved (significantly reduced); HbA1c: improved (significantly reduced) |
| 9 Juhász et al. 2026 | systematic review | fenugreek (12 seed powder, 7 seed extract, 1 leaf extract) plus guar, locust bean and tara gum; not reported; not reported; vs. guar gum, locust bean gum, tara gum | glycemic outcomes: improved |
| 10 Amiri et al. 2026 | systematic review | Fenugreek (Trigonella foenum-graecum), form unspecified | Hypoglycemia |
| 11 Al-Makhmari et al. 2025 | systematic review | Fenugreek (Trigonella foenum-graecum), form unspecified; vs. other herbs or controls in the included studies | glycaemic control: improved |
| 12 Chehregosha et al. 2025 | meta-analysis | Fenugreek seed (Trigonella foenum-graecum); vs. Control group | Fasting blood glucose: improved (WMD: - 16.75 mg/dl; 95 % CI: - 23.36, - 10.15; p<0.001); 2-hr postprandial glucose: improved (WMD: - 22.28 mg/dl; 95 % CI: - 34.42 to - 10.15; p<0.001); HbA1c: improved (WMD: - 0.63 mg/dl; 95 % CI: - 0.76 to - 0.51; p<0.001) |
| 13 de et al. 2024 | systematic review | Flour-based foods, including fenugreek powder; 1.5 g to 36 g/day; six weeks to 120 days; vs. Control groups of included RCTs | parameters of glucose homeostasis: improved (significant results) |
| 14 Shakil et al. 2024 | meta-analysis | Fenugreek seed, powder form; 2-5 mg; vs. Control | Fasting blood sugar: improved (P<0.001); HbA1c: improved (P<0.001); Postprandial glucose: improved (P<0.001) |
Further studies in this area: 17 18 19 20 21 22 23 25 26 27 29 30 31 32 34 49 55 59 61 62 63 69 71 72 74 75 76 78 80 81 82 85 88 93 94 95 96 100 104 106 107 109 110 111 112 114 117 118 121 123 124 126
Fenugreek (Trigonella Foenum-Graecum) and Blood Lipids: Human Studies
Several meta-analyses found lower triglycerides 34719 and higher HDL cholesterol 3471819 than with control, as did one randomized study for triglycerides 62 and one for HDL cholesterol 61. Total and LDL cholesterol fell in two meta-analyses 47; others found no significant difference in LDL cholesterol 326 or in triglycerides 1826. Predominantly seed extracts were studied, along with ground seeds and, in individual works, unspecified seed forms. The strength of evidence is high, but many studies are small and short, and the seed form along with amount and standardized fraction remains unclear in several works.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 3 Kim et al. 2023 | meta-analysis · 706 participants | Fenugreek (form not specified); vs. Control group | Total cholesterol: improved (significantly improved); Triglycerides: improved (significantly improved); HDL-C: improved (significantly improved) |
| 4 Askarpour et al. 2020 | meta-analysis · 560 participants | Fenugreek supplementation (form not specified); vs. Control/placebo (not specified) | Total cholesterol: improved (WMD = -9.371 mg/dL; 95% CI: -15.419, -3.323, p = 0.002); Triglycerides: improved (WMD = -13.776 mg/dL; 95% CI: -26.636, -0.916, p = 0.036); LDL cholesterol: improved (WMD = -6.590 mg/Dl; 95% CI: -13.042, -0.137, p = 0.045) |
| 7 Heshmat-Ghahdarijani et al. 2020 | meta-analysis · 281 participants | Fenugreek supplementation (form not specified); vs. Control group or pre-post | Total cholesterol: improved (-1.13 [-1.88, -0.37]; p = .003); LDL cholesterol: improved (-1.26 [-2.09, -0.43]; p = .003); Triglycerides: improved (-1.07 [-1.82, -0.33]; p = 0.005) |
| 9 Juhász et al. 2026 | systematic review | fenugreek (12 seed powder, 7 seed extract, 1 leaf extract) plus guar, locust bean and tara gum; not reported; not reported; vs. guar gum, locust bean gum, tara gum | lipid parameters: unclear |
| 11 Al-Makhmari et al. 2025 | systematic review | Fenugreek (Trigonella foenum-graecum), form unspecified; vs. other herbs or controls in the included studies | lipid profile: improved |
| 17 Sarker et al. 2024 | review | Fenugreek seeds and isolated seed compounds | lipid profiles: improved |
| 18 Vajdi et al. 2024 | meta-analysis | Fenugreek supplementation (form unspecified); vs. Control group (clinical trials) | Total cholesterol (TC): improved (WMD: 33.10 mg/dL; 95 % CI: 64.31 to -1.88); LDL-C: improved (WMD: 29.14 mg/dL; 95 % CI: 55.45 to -2.83); HDL-C: improved (WMD: 5.68 mg/dL; 95 % CI: 3.51 to 7.85) |
| 19 Fakhr et al. 2023 | meta-analysis | Fenugreek preparations (form not specified in abstract); not reported; not reported; vs. Control groups of included RCTs | Triglycerides: improved (-20.12 mg/dL; 95 % CI: -34.238, -5.994; P < 0.001); HDL cholesterol: improved (WMD: 3.55 mg/dL; 95 % CI: 1.98, 5.12; P < 0.001) |
Further studies in this area: 25 26 31 32 41 51 61 62 64 71 76 81 85 89 95 96 97 99 106 109 118
Fenugreek (Trigonella Foenum-Graecum), Hormones and Testosterone: Human Studies
In men, meta-analyses found a small increase in total testosterone 524; a more recent review rates the evidence as very uncertain and saw no stable effect on free testosterone 8. Under strength training, testosterone rose in two placebo-controlled studies with extracts 5768, while in older men with prostate complaints it remained unchanged 38. In women during and after menopause, estradiol rose compared with placebo in two controlled studies 4165, but not in a third 36. In younger women with low sexual desire, estradiol and free testosterone rose 43. Mixed preparations of fenugreek with shatavari 35, with Lespedeza cuneata 84, with minerals such as Testofen 58 or with added nutrients 40 show only what the respective mixture does. The findings come predominantly from seed extracts, partly standardized, partly hydroalcoholic; for ground seeds, infusion or germinated seeds, no controlled results are available in this area. The populations and endpoints are very different, and several studies were small or of short duration.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 5 Isenmann et al. 2023 | meta-analysis · 449 participants | Fenugreek extracts; chronic application; vs. control group | total testosterone: improved (SMD: 0.32; 95% CI: 0.09 0.55); free testosterone: no difference (SMD: 0.24; 95% CI: -0.04, 0.52) |
| 8 Yang et al. 2026 | meta-analysis | Oral fenugreek-derived preparations (form not specified); vs. Placebo | Total testosterone (SMD): improved (SMD: 0.25, 95% CI: 0.02, 0.48; p = 0.037); Free testosterone (SMD): no difference (SMD: 0.08, 95% CI: -0.48, 0.63; p = 0.725) |
| 24 Mansoori et al. 2020 | meta-analysis | Fenugreek extract (glycoside extract); vs. Control group | Total serum testosterone: improved |
| 31 Singh et al. 2023 | randomised controlled · 208 participants | Furocyst®, patented standardized Trigonella foenum-graecum extract; 2 capsules of 500 mg/day; not reported; vs. placebo (95) vs. Furocyst® (113), double-blind randomized | LH and FSH: improved; TSH: improved; prolactin and SHBG: improved |
| 36 Steels et al. 2017 | randomised controlled · 115 participants | Standardized de-husked Trigonella foenum-graecum seed extract; 600 mg per day; 12 weeks; vs. Placebo, double-blind randomized | Serum estradiol levels: no difference |
| 38 Rao et al. 2020 | randomised controlled · 100 participants | standardised Trigonella foenum-graecum (fenugreek) extract; 600 mg per day orally; 12 weeks; vs. placebo, double-blind randomised | testosterone, free testosterone, SHBG: no difference (remained unchanged) |
| 41 Shamshad et al. 2016 | randomised controlled · 88 participants | standardized fenugreek extract (FenuSMART™); 1000 mg/day; 90 days; vs. placebo, double-blind randomized | plasma estradiol: improved (increase in plasma estradiol (120%)) |
| 43 Rao et al. 2015 | randomised controlled · 80 participants | standardised Trigonella foenum-graecum seed extract (Libifem); 600 mg/day; two menstrual cycles (8 weeks); vs. placebo, double-blind, randomised | free testosterone: improved (significant increase); estradiol (E2): improved (significant increase) |
Further studies in this area: 47 57 65 68 74 95 96 97 98 104 108
Fenugreek (Trigonella Foenum-Graecum), Appetite and Satiety: Human Studies
In two placebo-controlled studies with healthy men, a seed extract reduced spontaneous fat consumption, in one of them only at the higher dose 6977. Isolated fenugreek fiber at breakfast increased satiety, but energy intake at the lunch buffet did not differ significantly from control 75. Total energy intake also did not differ significantly with seed extract 77. In a small crossover study with nine women, fenugreek tea reduced hunger and increased satiety compared with placebo tea, without changing food intake at the lunch buffet 79. The findings come from small, short investigations with seed extract, isolated fiber and tea, and the strength of evidence is moderate.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 69 Chevassus et al. 2010 | randomised controlled · 39 participants | hydro-alcoholic fenugreek seed extract; fixed dose (amount not stated); 6 weeks; vs. placebo, double-blind, randomized | fat reported energy intake/total energy expenditure ratio: improved (0.26 +/- 0.02 vs. 0.30 +/- 0.01; P = 0.032) |
| 74 Bhalerao et al. 2026 | randomised controlled · 20 participants | seed powder of T. foenum-graecum, T. balansae or combination; 2–3 g/day; 14 days; vs. three groups: FS1, FS2, FS3 | subjective appetite improvement: unclear (4 participants in each group) |
| 75 Mathern et al. 2009 | randomised controlled · 18 participants | isolated fenugreek fiber in test breakfast; 0 g, 4 g or 8 g; 3.5 h postprandial; vs. 0 g (control) vs. 4 g vs. 8 g | satiety and fullness ratings (VAS): improved (P < 0.05); hunger and prospective food consumption (VAS): improved (P < 0.05); energy intake at ad libitum lunch buffet: no difference (p = 0.11) |
| 77 Chevassus et al. 2009 | randomised controlled · 12 participants | fenugreek seed extract; 588 and 1176 mg; three 14-day periods, 14-day washout; vs. placebo, double-blind, randomized, cross-over | Daily fat consumption: improved (3.73 vs. 4.51 MJ day(-1), -17.3% vs. placebo, 95% CI -1.51 to -0.05, n = 12, P = 0.038); Total energy intake: no difference (9.97 vs. 11.29 MJ day(-1), -11.7% vs. placebo, 95% CI -2.91 to 0.26, n = 12, P = 0.094) |
| 79 Bae et al. 2015 | randomised controlled · 9 participants | Fenugreek tea (FGT) compared with fennel tea and placebo tea; vs. Placebo tea, 3-way crossover, single-blinded | Subjective hunger (VAS): improved (p < 0.05); Prospective food consumption (VAS): improved (p < 0.05); Feelings of fullness (VAS): improved (p < 0.05) |
Fenugreek (Trigonella Foenum-Graecum), Breastfeeding and Milk Production: Human Studies
Among mothers of preterm infants, milk volume was higher with fenugreek capsules than with placebo on the seventh day, but no longer significant on the fifteenth day; prolactin and the weight of the newborns did not differ 47. An herbal nursing tea with fenugreek increased milk volume on the third day after birth compared with placebo 48. In a randomized study, mothers drank black tea with or without fenugreek seed 45. With fenugreek, infant weight, head circumference, wet diapers and stools increased compared with baseline, but not in the comparison group 45. Given alone, fenugreek did not improve breastfeeding success in a randomized study; only together with honey did it increase 46. The evidence is weak; the studies tested different preparations such as capsules, tea and drops and sometimes mixtures, so the findings cannot readily be transferred to the seed alone.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 45 Ghasemi et al. 2015 | randomised controlled · 78 participants | Herbal tea with 7.5 g fenugreek seed powder plus 3 g black tea powder; 7.5 g fenugreek seed powder, three times a day; four weeks; vs. Herbal tea with 3 g black tea powder, three times a day | infant weight gain: unclear (5282.0513 ± 1021.51121 to 6383.0769 ± 952.06190); head circumference: unclear (38.3103 ± 1.62736 to 39.9256 ± 1.50660); number of wet diapers per day: unclear (5.2821 ± 0.93044 to 8.1648 ± 1.20620) |
| 47 Rouhi et al. 2025 | randomised controlled · 68 participants | Fenugreek capsules (500 mg) vs. placebo; 500 mg three times daily; from day 5 to day 14 after delivery; vs. Placebo capsules | Breast milk volume on day 7: improved (p =0.017); Breast milk volume on day 15: no difference (p =0.073) |
| 105 Damanik et al. 2006 | study | Fenugreek seeds (comparison group); 28 days; vs. Coleus amboinicus and Molocco+B12 tablets | milk volume: improved (20%) |
| 118 Nagulapalli et al. 2017 | review | Fenugreek (seeds, extract) | galactogogue effect: improved |
| 119 Dietz et al. 2016 | review | Trigonella foenum-graecum (fenugreek) as galactagogue | Efficacy as galactagogue: unclear |
| 122 Zapantis et al. 2012 | review | Fenugreek as a galactagogue herb | Milk supply: improved |
| 125 2006 | review | Fenugreek seeds, also in multi-ingredient mixtures; 1 to 6 g daily; about 25 g or more daily may lower cholesterol and blood sugar; vs. Placebo or no treatment; some multi-ingredient combinations | Milk supply: improved (43% thought it increased milk supply); Milk supply: worsened (5% thought it decreased their milk supply); Galactogogue effect: improved (mild galactogogue effect) |
Fenugreek (Trigonella Foenum-Graecum): Further Outcomes in Studies
In three placebo-controlled studies, extracts from seeds or seed husk alleviated menopausal symptoms such as hot flashes 364165. In first-time mothers after birth, a seed extract improved self-reported sleep quality compared with placebo 50. In menstrual pain, seed powder alleviated pain intensity more than placebo 86; against the painkiller mefenamic acid, it acted similarly 56. With seed extract, muscle strength rose more than with placebo in several controlled studies 60646883; with training, body fat percentage also fell 576483. One meta-analysis found lower systolic blood pressure 19, a placebo-controlled study in type 2 diabetes only lower diastolic 49. Two further studies showed reductions only compared with baseline 4263. A nursing tea of fenugreek, bitter fennel, anise, coriander and other herbs showed no difference compared with placebo in quality of life and breastfeeding self-efficacy 54. A fiber mixture of fenugreek, guar gum and wheat bran lowered BMI and waist circumference only compared with baseline 37. The strength of evidence is high, but many studies are small and short, and the forms studied and standardized fractions are often not precisely stated.
| Study | Design · participants | Preparation · dose · duration · comparison | Result |
|---|---|---|---|
| 1 Mohit et al. 2026 | meta-analysis · 1,171 participants | Fenugreek supplements (form not specified in abstract); Subgroup >1 g/day; vs. Control group | Alkaline phosphatase (ALP): no difference (SMD = -0.21, 95% CI = -0.44, 0.03); Aspartate aminotransferase (AST): no difference (WMD = 0.03 IU/L, 95% CI = -0.12 to 0.18); Alanine aminotransferase (ALT): no difference (WMD = -1.41 IU/L, 95% CI = -3.07, 0.26) |
| 3 Kim et al. 2023 | meta-analysis · 706 participants | Fenugreek (form not specified); vs. Control group | Body mass index: no difference (no significant differences) |
| 4 Askarpour et al. 2020 | meta-analysis · 560 participants | Fenugreek supplementation (form not specified); vs. Control/placebo (not specified) | Body weight: no difference (WMD = 0.223 kg; 95% CI: -0.509, 0.955, p = 0.551); Body mass index: no difference (WMD = 0.091 kg/m2; 95% CI: -0.244, 0.426, p = 0.596) |
| 5 Isenmann et al. 2023 | meta-analysis · 449 participants | Fenugreek extracts; chronic application; vs. control group | lean body mass: no difference (SMD: 0.19; 95% CI: -0.10, 0.49); fat mass: no difference (SMD: -0.19; 95% CI: -0.44, 0.05); leg press performance: no difference (SMD: 0.22; 95% CI: -0.02, 0.47) |
| 6 Amini et al. 2023 | meta-analysis · 373 participants | Fenugreek seed supplementation; Subgroup analysis: ≥ 15 g/day; Subgroup analysis: ≤ 12 weeks; vs. Control group (placebo/no supplementation) | Systolic blood pressure: improved (WMD: 3.46 mmHg, 95% CI - 6.33, - 0.59, P=0.018); Diastolic blood pressure: no difference (WMD: 3.19 mmHg; 95% CI, - 5.82 to 12.21, P=0.488) |
| 9 Juhász et al. 2026 | systematic review | fenugreek (12 seed powder, 7 seed extract, 1 leaf extract) plus guar, locust bean and tara gum; not reported; not reported; vs. guar gum, locust bean gum, tara gum | body weight and body mass index: unclear |
| 10 Amiri et al. 2026 | systematic review | Fenugreek (Trigonella foenum-graecum), form unspecified | Most common adverse effect; Allergic reactions; Maple syrup odor in urine, sweat, or skin |
| 13 de et al. 2024 | systematic review | Flour-based foods, including fenugreek powder; 1.5 g to 36 g/day; six weeks to 120 days; vs. Control groups of included RCTs | blood pressure measurements: improved (improvements) |
Further studies in this area: 16 18 19 25 28 31 32 34 36 38 41 42 43 44 47 49 50 52 53 56 57 59 60 61 62 63 64 65 66 67 68 69 70 73 81 83 86 87 90 91 92 95 96 97 98 101 102 103 110 113 115 116 118 120 125
4. How Is Fenugreek (Trigonella Foenum-Graecum) Dosed? Preparation, Dose and Duration in Studies
The studies predominantly used seed extracts, some standardized to furostanol saponins such as Furocyst, Fenfuro or Fenuflakes, as well as ground seeds, infusions and, in individual papers, isolated galactomannan fiber. For whole and germinated seeds, hardly any controlled results are available in the areas evaluated. The doses and treatment durations are shown in the table.
| Preparation or form | Dose | Duration | Study |
|---|---|---|---|
| Furocyst®, patented standardized Trigonella foenum-graecum extract | 2 capsules of 500 mg/day | not reported | 31 |
| Furocyst, fenugreek seed extract rich in furostanolic saponins | Furocyst twice daily (BD) | 12 weeks (three months) | 32 |
| lactation cookies with galactagogues (fenugreek, oatmeal, brewer's yeast, flax seeds) | 56.5 g cookies daily | 1 month | 33 |
| Fenfuro, fenugreek seed extract enriched in furostanolic saponins | 500 mg twice daily | 90 days | 34 |
| Fenavari, standardized extract of Trigonella foenum-graecum and Asparagus racemosus | 300 mg or 500 mg once daily | 84 days | 35 |
| Standardized de-husked Trigonella foenum-graecum seed extract | 600 mg per day | 12 weeks | 36 |
| Fibernat, fiber mixture of fenugreek, guar gum and wheat bran | 10 g twice daily | 6 months | 37 |
| standardised Trigonella foenum-graecum (fenugreek) extract | 600 mg per day orally | 12 weeks | 38 |
| Agent containing fenugreek, olive leaf polyphenols and bergamot extract | — | 6 months | 39 |
| TrigozimR fenugreek extract with essential nutrients | 0, 600, 1200, 1800 mg/day, 3 tablets | 12 weeks | 40 |
| standardized fenugreek extract (FenuSMART™) | 1000 mg/day | 90 days | 41 |
| fenugreek seed extract | 5 cc | 4 months | 42 |
| standardised Trigonella foenum-graecum seed extract (Libifem) | 600 mg/day | two menstrual cycles (8 weeks) | 43 |
| Aqueous extract of fenugreek seeds as syrup | — | 4 weeks | 44 |
| Herbal tea with 7.5 g fenugreek seed powder plus 3 g black tea powder | 7.5 g fenugreek seed powder, three times a day | four weeks | 45 |
5. Is Fenugreek (Trigonella Foenum-Graecum) Safe? Side Effects in Studies
The controlled studies with fenugreek alone report good tolerability without serious side effects 33134384147515657. Mild gastrointestinal complaints are mentioned most frequently 31026. Possible hypoglycemia, hypokalemia, allergic reactions and drug interactions are mentioned occasionally 10; details are shown in the table.
| Study | Reported side effects |
|---|---|
| 1 Mohit et al. 2026 | Safety should be further investigated |
| 3 Kim et al. 2023 | Mild gastrointestinal side effects; no severe adverse events, no hepatic or renal toxicity |
| 8 Yang et al. 2026 | Safety summarized descriptively, no numbers reported |
| 9 Juhász et al. 2026 | not reported |
| 10 Amiri et al. 2026 | Mild gastrointestinal discomfort most common; hypoglycemia, potential hypokalemia, allergic reactions, maple syrup odor, drug interactions |
| 11 Al-Makhmari et al. 2025 | Safety profiles noted as needing consideration, no data given |
| 16 Hassanzadeh et al. 2024 | Side effects reported but not quantified |
| 19 Fakhr et al. 2023 | not reported |
| 23 Willcox et al. 2021 | no serious adverse effects reported |
| 26 Gong et al. 2016 | No liver or kidney toxicity; mainly gastrointestinal discomfort |
| 28 Posadzki et al. 2013 | Only minor adverse effects reported |
| 31 Singh et al. 2023 | no significant adverse events observed |
6. What Remains Open: Limits of the Evidence
- Many studies are small and of short duration, which limits the informative value despite high certainty of evidence in individual areas.
- The seed form together with the amount and standardized proportion remains unclear in several papers, so that findings cannot always be assigned to a preparation.
- For ground seeds, infusion and germinated seeds, no controlled results are available in several areas.
- True combination products such as breastfeeding teas with fennel and anise or a fiber mixture with guar gum and wheat bran do not allow any conclusion about the seed alone 3754.
- The populations and endpoints studied are very different, which makes comparison between the studies difficult.
7. Bottom Line: What Is Established About Fenugreek (Trigonella Foenum-Graecum)
Fenugreek seed extracts and ground seeds showed favorable effects on blood sugar and blood lipids in several controlled studies and meta-analyses; for testosterone in men, the increases are small and still uncertain. Placebo-controlled studies also found initially more breast milk, fewer menopausal symptoms and menstrual pain, as well as less body fat and more muscle strength with training. The certainty of evidence is high in several areas, but many studies are small and short, and the seed form studied together with the amount and standardized proportion often remains unclear. Next to be clarified are larger, longer studies with precisely described preparation; findings on combination products apply only to the respective mixture.
Frequently Asked Questions
How well has Fenugreek (Trigonella foenum-graecum) been studied in humans?
We evaluated 138 human studies on Fenugreek (Trigonella foenum-graecum), including 64 randomised controlled trials and 30 meta-analyses or systematic reviews; the controlled studies include 3,978 participants in total. As of 11 October 2026.
Does Fenugreek (Trigonella foenum-graecum) help with blood Glucose and Sugar Metabolism? What the studies show
Does Fenugreek (Trigonella foenum-graecum) help with blood Lipids? What the studies show
Does Fenugreek (Trigonella foenum-graecum) help with hormones and Testosterone? What the studies show
Does Fenugreek (Trigonella foenum-graecum) help with appetite and Satiety? What the studies show
Does Fenugreek (Trigonella foenum-graecum) help with breastfeeding and Milk Production? What the studies show
Which forms of fenugreek were studied?
Seed extracts were tested most frequently, some standardized to furostanol saponins such as Furocyst, Fenfuro or Fenuflakes. In addition, ground seeds, infusions and, in individual papers, isolated galactomannan fiber were used. For whole and germinated seeds, hardly any controlled results are available in the areas evaluated.
How well is fenugreek tolerated?
Do human studies show an effect on blood sugar?
What do the studies on blood lipids show?
Do the results also apply to combination products with other ingredients?
Sources
- 1Mohit M, Mahmoudizadeh M, Hashempur MH, Soltani M, Kazemi A · 2026
- 2Shabil M, Bushi G, Bodige PK, Maradi PS, Patra BP, Padhi BK et al. · 2023
- 3Kim J, Noh W, Kim A, Choi Y, Kim YS · 2023
- 4Askarpour M, Alami F, Campbell MS, Venkatakrishnan K, Hadi A, Ghaedi E · 2020
- 5Isenmann E, Alisauskas P, Flenker U, Schalla J, Diel P · 2023
- 6Amini MR, Payandeh N, Sheikhhossein F, Pourreza S, Ghalandari H, Askarpour M et al. · 2023
- 7Heshmat-Ghahdarijani K, Mashayekhiasl N, Amerizadeh A, Teimouri Jervekani Z, Sadeghi M · 2020
- 8Yang P, Niu Z, Guo J, Huang T, Chang D, Huang X · 2026
- 9Juhász AE, Kara TK, Csajbókné Csobod É, Juhász R · 2026
- 10Amiri Ardekani E, Parvizi MM, Zare R, Mosaffa Jahromi M, Rampp T, Pasalar M · 2026
- 11Al-Makhmari S, Al-Aufi A, Al-Kindi S, Alriyami M, Sakr H, Boulassel MR et al. · 2025
- 12Chehregosha F, Fakhr L, Tarighat-Esfanjani A, Maghsoumi-Norouzabad L · 2025
- 13The effect of flour-based foods intake in the reduction of cardiometabolic risk: A systematic reviewde Souza LVM, Dos Santos KS, Barcellos TMA, Alvares TDS · 2024
- 14Shakil S, Akhtar SE, Ali A, Antony M, Antony I, Mansour E et al. · 2024
- 15Chehregosha F, Fakhr L, Tarighat-Esfanjani A, Maghsoumi-Norouzabad L · 2024
- 16Hassanzadeh R, Shabani F, Montazeri M, Mirghafourvand M · 2024
- 17Sarker DK, Ray P, Dutta AK, Rouf R, Uddin SJ · 2024
- 18Vajdi M, Noshadi N, Bonyadian A, Golpour-Hamedani S, Alipour B, Pourteymour Fard Tabrizi F et al. · 2024
- 19Fakhr L, Chehregosha F, Zarezadeh M, Chaboksafar M, Tarighat-Esfanjani A · 2023
- 20Mackonochie M, Rodriguez-Mateos A, Mills S, Rolfe V · 2023
- 21Correia AGDS, Alencar MB, Dos Santos AN, da Paixão DCB, Sandes FLF, Andrade B et al. · 2023
- 22Araújo EG, Oliveira DMSL, Martins CC, Stefani CM · 2022
- 23Willcox ML, Elugbaju C, Al-Anbaki M, Lown M, Graz B · 2021
- 24Mansoori A, Hosseini S, Hosseini S, Zilaee M, Hormoznejad R, Fathi M · 2020
- 25Khodamoradi K, Khosropanah MH, Ayati Z, Chang D, Nasli-Esfahani E, Ayati MH et al. · 2020
- 26Gong J, Fang K, Dong H, Wang D, Hu M, Lu F · 2016
- 27Neelakantan N, Narayanan M, de Souza RJ, van Dam RM · 2014
- 28Posadzki P, Watson LK, Ernst E · 2013
- 29Complementary and alternative medicine for the treatment of type 2 diabetesNahas R, Moher M · 2009
- 30Are Ayurvedic herbs for diabetes effective?Shekelle PG, Hardy M, Morton SC, Coulter I, Venuturupalli S, Favreau J et al. · 2005
- 31Singh A, Gainder S, Banerjee P, Goel A, Kumar P, Mondal B et al. · 2023
- 32Shukla A, Singh R, Gupta A, Goel A, Tiwari K, Singh SK · 2024
- 33Palacios AM, Cardel MI, Parker E, Dickinson S, Houin VR, Young B et al. · 2023
- 34Verma N, Usman K, Patel N, Jain A, Dhakre S, Swaroop A et al. · 2016
- 35Kashinath RN, Bhat VV, Morde A, Joshua L, Thomas JV · 2026
- 36
- 37Is dietary fiber beneficial in chronic ischemic heart disease?Vajifdar BU, Goyal VS, Lokhandwala YY, Mhamunkar SR, Mahadik SP, Gawad AK et al. · 2000
- 38
- 39Florentin M, Liberopoulos E, Elisaf MS, Tsimihodimos V · 2019
- 40Lee-Ødegård S, Gundersen TE, Drevon CA · 2024
- 41Shamshad Begum S, Jayalakshmi HK, Vidyavathi HG, Gopakumar G, Abin I, Balu M et al. · 2016
- 42Foroumandi E, Javan R, Moayed L, Fahimi H, Kheirabadi F, Neamatshahi M et al. · 2023
- 43Rao A, Steels E, Beccaria G, Inder WJ, Vitetta L · 2015
- 44Emtiazy M, Oveidzadeh L, Habibi M, Molaeipour L, Talei D, Jafari Z et al. · 2018
- 45Ghasemi V, Kheirkhah M, Vahedi M · 2015
- 46Simbar M, Nazarpour S, Mojab F, Kholosi Badr F, Khorrami M, Jafari Torkamani Z et al. · 2022
- 47Rouhi M, Hossieni MB, Khodaie L, Mohammad-Alizadeh-Charandabi S, Mirghafourvand M · 2025
- 48Turkyılmaz C, Onal E, Hirfanoglu IM, Turan O, Koç E, Ergenekon E et al. · 2011
- 49Hassani SS, Fallahi Arezodar F, Esmaeili SS, Gholami-Fesharaki M · 2019
- 50Mohammadi S, Karimi FZ, Salari R, Mazloom SR · 2026
- 51Badiee Gavarti M, Askari A, Roohafza H, Askari M, Teimouri Jervekani Z, Kaveh S et al. · 2025
- 52Safary M, Hakimi S, Mobaraki-Asl N, Amiri P, Tvassoli H, Delazar A · 2020
- 53Mazalzadeh F, Hekmat K, Namjouyan F, Saki A · 2020
- 54Wagner CL, Boan AD, Marzolf A, Finch CW, Morella K, Guille C et al. · 2019
- 55
- 56Inanmdar W, Sultana A, Mubeen U, Rahman K · 2016
- 57Wankhede S, Mohan V, Thakurdesai P · 2016
- 58Steels E, Rao A, Vitetta L · 2011
- 59Evaluation of Fenugreek (Trigonella foenum-graceum L.), Effects Seeds Extract on Insulin Resistance in Women with Polycystic Ovarian SyndromeHassanzadeh Bashtian M, Emami SA, Mousavifar N, Esmaily HA, Mahmoudi M, Mohammad Poor AH · 2013
- 60Hausenblas HA, Conway KL, Coyle KRM, Barton E, Smith LD, Esposito M et al. · 2020
- 61Chehregosha F, Maghsoumi-Norouzabad L, Mobasseri M, Fakhr L, Tarighat-Esfanjani A · 2024
- 62Pickering E, Steels E, Rao A, Steadman KJ · 2022
- 63Hadi A, Arab A, Hajianfar H, Talaei B, Miraghajani M, Babajafari S et al. · 2020
- 64Poole C, Bushey B, Foster C, Campbell B, Willoughby D, Kreider R et al. · 2010
- 65Khanna A, John F, Das S, Thomas J, Rao J, Maliakel B et al. · 2020
- 66Herrick LP, Goh J, Menke W, Campbell MS, Fleenor BS, Abel MG et al. · 2020
- 67Goh J, Menke W, Herrick LP, Campbell MS, Abel MG, Fleenor BS et al. · 2020
- 68Tamoli S, Mundhe N, Kolhe G, Khatau K, Dubey R, Mulye NN · 2025
- 69Chevassus H, Gaillard JB, Farret A, Costa F, Gabillaud I, Mas E et al. · 2010
- 70Babaei A, Taghavi SA, Mohammadi A, Mahdiyar MA, Iranpour P, Ejtehadi F et al. · 2020
- 71Effect of Trigonella foenum-graecum (fenugreek) seeds on glycaemic control and insulin resistance in type 2 diabetes mellitus: a double blind placebo controlled studyGupta A, Gupta R, Lal B · 2001
- 72Deshpande PO, Gokhale CA, Bhaskaran S, Gayathri R, Abirami K, Anjana RM et al. · 2025
- 73Balasundaram N, Narayanan MA, Antony LSA, Kumar SR, Anandan S · 2024
- 74
- 75Mathern JR, Raatz SK, Thomas W, Slavin JL · 2009
- 76Najdi RA, Hagras MM, Kamel FO, Magadmi RM · 2019
- 77Chevassus H, Molinier N, Costa F, Galtier F, Renard E, Petit P · 2009
- 78Robert SD, Ismail AA, Rosli WI · 2016
- 79
- 80Losso JN, Holliday DL, Finley JW, Martin RJ, Rood JC, Yu Y et al. · 2009
- 81Mirgaloybayat S, Akbari Sene A, Jayervand F, Vazirian M, Mohazzab A, Kazerooni M · 2024
- 82Gupta RS, Grover AS, Kumar P, Goel A, Banik SP, Chakraborty S et al. · 2024
- 83
- 84
- 85Gaddam A, Galla C, Thummisetti S, Marikanty RK, Palanisamy UD, Rao PV · 2015
- 86Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrheaYounesy S, Amiraliakbari S, Esmaeili S, Alavimajd H, Nouraei S · 2014
- 87Slivka D, Cuddy J, Hailes W, Harger S, Ruby B · 2008
- 88Hota D, Padhy BM, Maiti R, Bisoi D, Sahoo JP, Patro BK et al. · 2024
- 89Geberemeskel GA, Debebe YG, Nguse NA · 2019
- 90Ansari M, Sadeghi P, Mahdavi H, Fattahi-Dolatabadi M, Mohamadi N, Asadi A et al. · 2019
- 91Nathan J, Panjwani S, Mohan V, Joshi V, Thakurdesai PA · 2014
- 92Elagib H, Alshammari SS, Alsadoon WK, Zahra A · 2023
- 93Al-Luwaym AH, Al-Quwaidhi AJ, Al-Ghadeeb RB · 2024
- 94Alzahrani MA, Alsiary KA, Khan MA, Bushnaq A, Alzahrani B, Salama M et al. · 2023
- 95Sankhwar P, Jaiswar SP, Yadav S, Awasthi V, Goel A, Kumar P et al. · 2023
- 96Sankhwar SN, Kumar P, Bagchi M, Rungta M, Bagchi D · 2023
- 97Maheshwari A, Verma N, Swaroop A, Bagchi M, Preuss HG, Tiwari K et al. · 2017
- 98Swaroop A, Jaipuriar AS, Gupta SK, Bagchi M, Kumar P, Preuss HG et al. · 2015
- 99Vitulano N, Guida P, Abrusci V, Ceci E, De Nicolò EV, Martinotti S et al. · 2025
- 100Velpandian T, Gowtham L, Nath M, Tuli A, Sharma G, Halder N · 2025
- 101Nguyen SM, Ko Ko N, Sattar AS, Gucuk Ipek E, Ali S · 2017
- 102Al Harrak Y, Lkhoyaali S, Lamsyah O, Tine MM, Bechar H, Benabdallah G et al. · 2025
- 103Aldhilan MM, Abdel-Wanis ME · 2023
- 104Kiss R, Szabó K, Gesztelyi R, Somodi S, Kovács P, Szabó Z et al. · 2018
- 105Lactagogue effects of Torbangun, a Bataknese traditional cuisineDamanik R, Wahlqvist ML, Wattanapenpaiboon N · 2006
- 106Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetesSharma RD, Raghuram TC, Rao NS · 1990
- 107Schenk S, Pignolet-Marti A, Graz B, Cavin AL, Puder JJ · 2026
- 108Skrzypiec-Spring M, Pokrywka A, Kuliczkowska-Płaksej J, Szeląg A, Bolanowski M · 2025
- 109Fallah Huseini H, Haghighi M, Kianbakht S, Ziaee M · 2025
- 110Febriyanti RM, Levita J, Diantini A · 2024
- 111McBenedict B, Orfao AL, Goh KS, Yau RCC, Alphonse B, Machado Lima J et al. · 2024
- 112Srivastava SP, Upadhyay P, Das S, Tiwari N, Mishra S, Tripathi SM · 2024
- 113Melethil S, Yousef E · 2024
- 114Cortez-Navarrete M, Pérez-Rubio KG, Escobedo-Gutiérrez MJ · 2023
- 115Varshney H, Siddique YH · 2023
- 116Hatfield J, Saad S, Housewright C · 2022
- 117Fenugreek (Trigonella foenum-graecum): Nutraceutical values, phytochemical, ethnomedicinal and pharmacological overviewRuwali P, Pandey N, Jindal K, Singh RV · 2022
- 118Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A · 2017
- 119Dietz BM, Hajirahimkhan A, Dunlap TL, Bolton JL · 2016
- 120John LJ, Shantakumari N · 2015
- 121
- 122Zapantis A, Steinberg JG, Schilit L · 2012
- 123
- 124Xie W, Zhao Y, Zhang Y · 2011
- 125Fenugreek· 2006
- 126Non-Pharmaceutical Intervention Options For Type 2 Diabetes: Complementary & Integrative Health Approaches (Including Natural Products And Mind/Body Practices)McKennon SA · 2000
Every statement on this page carries its evidence tier — proven, plausible or hypothesis — and leads to the original work. The decision in the individual case rests with the practitioner; we provide the connections.